|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/02 | |||
| A61K 47/26 | |||
| A61K 9/00 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2081553 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07839335.2 |
| Europos patento paraiškos padavimo data | 2007-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-07-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/021477 |
| Data | 2007-10-05 |
| (87) | Numeris | WO 2008/045373 |
| Data | 2008-04-17 |
| (30) | Numeris | Data | Šalis |
| 850362 P | 2006-10-06 | US | |
| 850970 P | 2006-10-10 | US |
| (72) |
MCAULEY, Arnold, US
REHDER, Douglas, US
MATSUMURA, Masazumi, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | STABLE ANTIBODY FORMULATIONS |
| STABLE ANTIBODY FORMULATIONS |